These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 15501346)
1. [Non-lipid effects of statins in atherosclerosis]. Lévesque H Rev Med Interne; 2004 Nov; 25(11):783-5. PubMed ID: 15501346 [No Abstract] [Full Text] [Related]
2. Statins for atherosclerosis--as good as it gets? Ehrenstein MR; Jury EC; Mauri C N Engl J Med; 2005 Jan; 352(1):73-5. PubMed ID: 15635116 [No Abstract] [Full Text] [Related]
3. Antiinflammatory and immunomodulatory properties of statins. Shovman O; Levy Y; Gilburd B; Shoenfeld Y Immunol Res; 2002; 25(3):271-85. PubMed ID: 12018465 [TBL] [Abstract][Full Text] [Related]
4. Statins and endothelial dysfunction. Larose E; Ganz P Semin Vasc Med; 2004 Nov; 4(4):333-46. PubMed ID: 15861315 [TBL] [Abstract][Full Text] [Related]
5. Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia. Kumai T; Oonuma S; Matsumoto N; Takeba Y; Taniguchi R; Kamio K; Miyazu O; Koitabashi Y; Sekine S; Tadokoro M; Kobayashi S Life Sci; 2004 Mar; 74(17):2129-42. PubMed ID: 14969717 [TBL] [Abstract][Full Text] [Related]
9. The dichotomous role of nitric oxide in the pathogenesis of accelerated atherosclerosis associated with systemic lupus erythematosus. Levesque MC; Weinberg JB Curr Mol Med; 2004 Nov; 4(7):777-86. PubMed ID: 15579024 [TBL] [Abstract][Full Text] [Related]
10. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Schönbeck U; Libby P Circulation; 2004 Jun; 109(21 Suppl 1):II18-26. PubMed ID: 15173059 [TBL] [Abstract][Full Text] [Related]
11. Cracking down on caveolin: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in modulating edothelial cell nitric oxide production. Davis ME; Harrison DG Circulation; 2001 Jan; 103(1):2-4. PubMed ID: 11136674 [No Abstract] [Full Text] [Related]
12. Potential vascular benefits of statins. Kinlay S Am J Med; 2005 Dec; 118 Suppl 12A():62-7. PubMed ID: 16356810 [TBL] [Abstract][Full Text] [Related]
13. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes]. Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071 [TBL] [Abstract][Full Text] [Related]
14. [Some aspects of pleiotropic effects of statins in internal medicine]. Switalski M Pol Arch Med Wewn; 2003 Oct; 110(4):1173-9. PubMed ID: 14699676 [No Abstract] [Full Text] [Related]
15. Vascular health: the emerging appreciation of the endothelium. Talley JD J Ark Med Soc; 1997 Feb; 93(9):454-5. PubMed ID: 9046759 [No Abstract] [Full Text] [Related]
16. The expanding role of HMG-CoA reductase inhibitors (statins) in the prevention and treatment of ischemic heart disease. Chilton R; O'Rourke RA Curr Probl Cardiol; 2001 Dec; 26(12):734-64. PubMed ID: 11743453 [No Abstract] [Full Text] [Related]
17. Antioxidative effects of statins. Adam O; Laufs U Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762 [TBL] [Abstract][Full Text] [Related]